Tanner Pharma Group to Attend Pharmagora, PQMD, CPhI, US GCSG, and Asembia Conferences

For Immediate Release

Lindsey Stevens
Tanner Pharma Group

CHARLOTTE, N.C. – Key directors from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend several healthcare conferences throughout the upcoming month of April. The team will join other global executives for the following events:

 Pharmagora | April 7th – 8th | Paris, France
 PQMD Global Health Policy Forum | April 11th – 12th | Washington, D.C.
 CPhI North America | April 24th – 26th | Philadelphia, PA
 US GCSG Conference | April 29th – May 2nd | Atlanta, GA
 Asembia’s Specialty Pharmacy Summit | April 29th – May 2nd | Las Vegas, NV.

Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four synergistic divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.

Tanner Pharma representatives will include Richard Lambie, Global Director for TannerCTS, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Rob Keel, Director for TannerMAP.

Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
Diana Mendoza | dmendoza@tannerpharma.com | +1 704 552 8408

Tanner Pharma Group uses cookies on its website. By continuing to access this website you are agreeing to Tanner Pharma Group’s Data Privacy Policy. For more information, click here.